Search

PerkinElmer Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

13M

53M

Sales

19M

730M

P/E

Sector Avg

72.22

49.241

EPS

1.41

Dividend yield

0.18

Profit margin

7.329

Employees

11,000

EBITDA

8.8M

189M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

-10.72% downside

Dividends

By Acuity

Dividend yield

Sector Avg

0.18%

2.15%

Next Earnings

3 lis 2026

Next Dividend date

13 lis 2026

Next Ex Dividend date

15 sty 2027

Market Stats

By TradingEconomics

Market Cap

4B

17B

Previous open

0

Previous close

0

PerkinElmer Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

23 paź 2026, 20:13 UTC

Revvity Inc shares are trading modestly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher.

22 paź 2026, 21:41 UTC

Revvity Inc shares have declined in after-market trading, reaching their lowest point of the day after moving from a slight loss post-close.

21 paź 2026, 20:07 UTC

Correlated Moves

Revvity Inc shares are advancing, continuing an upward trend since Tuesday, while Charles River Laboratories is sharply higher with increased trading activity and volume.

20 paź 2026, 20:02 UTC

News

Revvity Inc. launches its AI-first Signals LabGistics solution to streamline scientific workflows in pharma and biotech, with positive outlook from Citrini Research.

19 paź 2026, 19:36 UTC

Correlated Moves

Revvity Inc shares are declining, facing speculation around Thermo Fisher Scientific Inc's upcoming earnings report, despite earlier reaching a session high.

16 paź 2026, 21:02 UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

15 paź 2026, 23:46 UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

14 paź 2026, 23:46 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

13 paź 2026, 20:13 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

12 paź 2026, 19:51 UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

8 paź 2026, 20:06 UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

7 paź 2026, 19:25 UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

6 paź 2026, 22:41 UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

5 paź 2026, 19:21 UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2 paź 2026, 19:45 UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

1 paź 2026, 20:03 UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

30 wrz 2026, 21:02 UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

29 wrz 2026, 19:36 UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

28 wrz 2026, 20:20 UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

25 wrz 2026, 20:01 UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

24 wrz 2026, 23:11 UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

23 wrz 2026, 20:07 UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

22 wrz 2026, 19:31 UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

21 wrz 2026, 23:56 UTC

Revvity Inc is trading modestly higher in after-market hours, positioned above its 20-day moving average and near the upper end of its one-month range.

16 wrz 2026, 20:07 UTC

Revvity Inc is trading higher, continuing a strong momentum with four consecutive sessions of gains and remaining well above its 20-day moving average.

15 wrz 2026, 22:02 UTC

Revvity Inc. shares are lower in after-market trading, reflecting broader market trends amid economic concerns following a significant drop in the NY Empire State Manufacturing Index.

14 wrz 2026, 20:08 UTC

Revvity Inc shares are higher in Monday's session, continuing a broader upward trend since Friday. The stock is above its 20-day moving average.

11 wrz 2026, 20:08 UTC

News

Revvity Inc will acquire Human Cell Design to enhance its Life Sciences sector reach. Shares are rising today after five consecutive lower sessions.

9 wrz 2026, 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

8 wrz 2026, 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

Peer Comparison

Price change

PerkinElmer Inc Forecast

Price Target

By TipRanks

-10.72% downside

12 Months Forecast

Average 141.75 USD  -10.72%

High 175 USD

Low 110 USD

Based on 14 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

4

Buy

10

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat